Portal de Periódicos da CAPES

Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein

2003; Springer Nature; Volume: 22; Issue: 20 Linguagem: Inglês

10.1093/emboj/cdg537

1460-2075

Claudio Hetz,

Endoplasmic Reticulum Stress and Disease

Article15 October 2003free access Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein Claudio Hetz Claudio Hetz Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile Search for more papers by this author Milene Russelakis-Carneiro Milene Russelakis-Carneiro Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland Search for more papers by this author Kinsey Maundrell Kinsey Maundrell Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland Search for more papers by this author Joaquin Castilla Joaquin Castilla Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland Department of Neurology, University of Texas Medical Branch, Galveston, Texas, TX, USA Search for more papers by this author Claudio Soto Corresponding Author Claudio Soto Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland Department of Neurology, University of Texas Medical Branch, Galveston, Texas, TX, USA Search for more papers by this author Claudio Hetz Claudio Hetz Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile Search for more papers by this author Milene Russelakis-Carneiro Milene Russelakis-Carneiro Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland Search for more papers by this author Kinsey Maundrell Kinsey Maundrell Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland Search for more papers by this author Joaquin Castilla Joaquin Castilla Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland Department of Neurology, University of Texas Medical Branch, Galveston, Texas, TX, USA Search for more papers by this author Claudio Soto Corresponding Author Claudio Soto Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland Department of Neurology, University of Texas Medical Branch, Galveston, Texas, TX, USA Search for more papers by this author Author Information Claudio Hetz1,2, Milene Russelakis-Carneiro1, Kinsey Maundrell1, Joaquin Castilla1,3 and Claudio Soto 1,3 1Serono Pharmaceutical Research Institute, 14 Chemin des Aulx, 1228 Plan les Ouates, Switzerland 2Instituto de Ciencias Biomédicas, Universidad de Chile, Santiago, Chile 3Department of Neurology, University of Texas Medical Branch, Galveston, Texas, TX, USA *Corresponding author. E-mail: [email protected] The EMBO Journal (2003)22:5435-5445https://doi.org/10.1093/emboj/cdg537 Correction(s) for this article Caspase-12 and endoplasmic reticulum stress mediate neurotoxicity of pathological prion protein15 September 2021 PDFDownload PDF of article text and main figures. ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinked InMendeleyWechatReddit Figures & Info Prion diseases are characterized by accumulation of misfolded prion protein (PrPSc), and neuronal death by apoptosis. Here we show that nanomolar concentrations of purified PrPSc from mouse scrapie brain induce apoptosis of N2A neuroblastoma cells. PrPSc toxicity was associated with an increase of intracellular calcium released from endoplasmic reticulum (ER) and up-regulation of several ER chaperones. Caspase-12 activation was detected in cells treated with PrPSc, and cellular death was inhibited by overexpression of a catalytic mutant of caspase-12 or an ER-targeted Bcl-2 chimeric protein. Scrapie-infected N2A cells were more susceptible to ER-stress and to PrPSc toxicity than non-infected cells. In scrapie-infected mice a correlation between caspase-12 activation and neuronal loss was observed in histological and biochemical analyses of different brain areas. The extent of prion replication was closely correlated with the up-regulation of ER-stress chaperone proteins. Similar results were observed in humans affected with sporadic and variant Creutzfeldt–Jakob disease, implicating for the first time the caspase-12 dependent pathway in a neurodegenerative disease in vivo, and thus offering novel potential targets for the treatment of prion disorders. Introduction Transmissible spongiform encephalopathies (TSEs), also known as prion disorders, are a group of clinically diverse, but mechanistically similar neurological diseases, such as Creutzfeldt–Jakob disease (CJD) in humans and bovine spongiform encephalopathy (BSE), scrapie and chronic wasting disease in animals. The hallmark pathological features of TSEs are the spongiform degeneration of the brain, accompanied by extensive neuronal loss, astrogliosis, and cerebral accumulation of a misfolded and protease-resistant form of the prion protein (Prusiner, 1998). No amino acid sequence or posttranslational differences have been detected between the normal host cell surface protein, PrPC, and its pathological form, PrPSc. The conversion of PrPC into PrPSc involves a conformational change whereby the α-helical content diminishes and the amount of β-sheet increases (Prusiner, 1998). Apoptosis is a programmed form of cell death, which plays a central role during development and homeostasis of multicellular organisms and has been implicated in a number of pathological conditions (Vaux and Korsmeyer, 1999; Reed, 2002). The central executioner molecules of apoptosis are a large family of cysteine proteases known as caspases (Budihardjo et al., 1999; Takahashi, 1999). Activation of caspase-dependent apoptosis may be initiated by cell surface receptors or by mitochondrial stress (Budihardjo et al., 1999). Recently, another apoptotic-regulatory pathway has been described, in which the induction of endoplasmic reticulum (ER) stress due to alteration of calcium homeostasis or accumulation of misfolded proteins, triggers the activation of an ER-resident caspase, termed caspase-12 (Nakagawa et al., 2000). Apoptosis has been described in the brains of patients affected by CJD, Fatal Familial Insomnia, scrapie-infected hamsters, mice and sheep (review in Hetz and Soto, 2003). Although a considerable effort has been made to understand the molecular basis of prion conversion, little is known about the mechanism by which this process is associated with the disease. Attempts to understand the molecular basis of neuronal dysfunction in prion diseases have led to the search for in vitro models to analyze the role of PrPSc in cellular death. The prion protein fragment spanning the sequence 106–126 (PrP106–126), corresponding to a putative transmembrane region of PrPC, has been extensively used to induce cell death in neuronal cultures (Forloni et al., 1993; O'Donovan et al., 2001). The major drawback of using PrP106–126 as a model is that although this sequence is present in several longer peptides isolated from cerebral amyloid plaques of patients suffering from GSS (Ghetti et al., 1996), the PrP106–126 peptide as such has never been found in vivo. Therefore, the relevance of the findings obtained with this peptide remains to be determined. The major aim of this study was to characterize the signaling pathways involved in neuronal death induced by highly purified PrPSc from mouse brains infected with experimental scrapie. It has been reported earlier that purified PrPSc leads to cell death (Post et al., 2000). However, the mechanism of cell death was not studied. Our findings show that PrPSc-induced apoptosis in vitro is associated with the induction of ER-stress and activation of caspase-12. Histological and biochemical analysis of brains from scrapie-sick mice and from humans affected by sporadic CJD (sCJD) and variant CJD (vCJD) showed the presence of activated caspase-12 and ER-stress inducible chaperones in brain areas exhibiting extensive neuronal death. These findings provide a novel target for TSE therapy and suggest a general mechanism of cell death in chronic neurodegenerative diseases. Results Purified mouse PrPSc induces caspase-3-dependent apoptosis in N2A cells N2A cells were chosen to characterize neurotoxicity of PrPSc purified from 139A scrapie-infected brains. N2A neuroblastoma cells were grown for 24 h in normal culture medium with low serum, and then different concentrations of PrPSc were added to the medium. After 48 h of incubation, the cells treated with PrPSc showed abnormal morphological changes, including cell shrinkage and aggregation of the cell bodies, followed by detachment of cells from the culture plate (Figure 1A). Quantification of cellular viability after PrPSc treatment revealed that cellular death occurred in a concentration-dependent manner in the nanomolar range (Figure 1B). Several controls were performed. First, to rule out the possibility that toxicity might be caused by contaminants carried over from the purification procedure, cells were treated with equivalent volumes of a sample prepared under the same conditions, but starting with normal mouse brains. The results showed no effect of this preparation (Figure 1C). In addition, experiments in which cells were treated with recombinant mouse PrPC (165 nM) showed no effect on neuronal survival (Figure 1C), suggesting that PrPSc toxicity is associated with its pathological conformation. In agreement with this hypothesis, pre-incubation of PrPSc with a small peptide that disrupts the β-sheet structure (peptide iPrP13), leads to a significant decrease in the toxicity of the protein (Figure 1C). We have previously shown that iPrP13 decreases the β-sheet structure of PrPSc, converting it into a protease-sensitive PrPC-like molecule (Soto et al., 2000). Finally, treatment of the cells with 100 nM PrP106–126 did not produce any cell death (Figure 1C). Cytotoxicity with this peptide was observed only when cells were treated with 1000-fold higher concentration (100 μM), compared with pure PrPSc, and only after several days of incubation in culture (Figure 1C). These data suggest that PrPSc neurotoxicity cannot simply be explained by a non-specific effect of an aggregated hydrophobic protein preparation. Figure 1.Purified PrPSc from 139A-scrapie infected brains induces caspase-3 dependent apoptosis of N2A cells. (A) Morphological changes observed in N2A neuroblastoma cells treated with 50 nM PrPSc for 48 h. (B) N2A cells were treated with different concentrations of PrPSc and cell viability was analyzed after 48 h by MTS assay. (C) As controls, cells were incubated with: 165 nM of recombinant mouse PrPC; 50 nM PrPSc pre-treated with 300 nM of β-sheet breaker peptide iPrP13 to decrease PrPSc-β sheet content; 100 nM or 100 μM of aggregated PrP106–126 peptide for 7 days; or 0.5% (v/v) preparation of normal brain homogenate following the same procedure as to purify PrPSc (N.B.). (D) Cells were incubated for 48 h with different concentrations of PrPSc, 100 nM recombinant PrPC or left untreated. Subsequently, cells were stained with PI and hypodiploid cell population was quantified by FACS analysis. (E) Cells were treated with 66 nM PrPSc for 6 h and then phosphatidylserine exposure on the cell surface was detected using annexin V–FITC. (F) Caspase-3 and caspase-8 activity in situ was determined by flow cytometry using the cell permeable substrates FAM-DEVD-fmk and FAM-IETD-fmk after treatment with PrPSc for 20 h. Non-treated cells (gray line), or cells treated with 50 nM PrPSc (black line). (G) Cells were incubated for 60 min with or without 100 μM Ac-DEVD-fmk (DEVD), 100 μM Ac-YVAD-fmk (YVAD) or 10 μM zVAD-fmk (zVAD). Then, PrPSc was added to a final concentration of 50 nM, and after 48 h cell survival was determined by the MTS assay. Data shown in (C, D and G) correspond to the means and standard deviations at two independent experiments performed in triplicate. Statistical analysis was performed by parametric t-test comparing each value with the untreated control. Download figure Download PowerPoint Quantification of DNA content after PI-staining revealed that hypodiploid cells could be detected after PrPSc treatment in a dose-dependent manner (Figure 1D). As controls, we used cells treated with recombinant PrPC, which showed no indication of apoptotic induction (Figure 1D). PrPSc-induced apoptosis was additionally confirmed by phosphatidylserine externalization to the cell surface, which is commonly observed at early stages of apoptosis. Appearance of phosphatidylserine at the cell surface was observed in 34% of the cells 6 h after treatment with 66 nM PrPSc (Figure 1E). Overall, these data indicate that nanomolar concentrations of purified PrPSc induce cellular death by apoptosis. To characterize the signalling pathways involved in PrPSc-induced apoptosis, we studied the activation of different caspases using cell permeable fluorogenic substrates (FAM-YEVD-fmk, FAM-DEVD-fmk, and FAM-IETD-fmk) to detect caspase-1, caspase-3 and caspase-8 activity, respectively. After PrPSc treatment, caspase-3 activation was observed progressively over time, reaching a maximum level at ∼20 h (Figure 1F). However, no significant activation of caspase-8 or caspase-1 was observed after 20 h of incubation with PrPSc (Figure 1F, data not shown). Treatment of N2A cells with 100 μM Ac-DEVD-fmk, a preferential caspase-3 inhibitor, completely abolished cellular death induced by 50 nM PrPSc (Figure 1G). Treatment with 100 μM Ac-YVAD-fmk, an inhibitor of interleukin-1 converting proteases, like caspase-1, or low doses of zVAD-fmk, a general caspase inhibitor that blocks mainly caspase-8 activation at this dose (Hetz et al., 2002a), had no significant effect on PrPSc-induced neuronal apoptosis. PrPSc-induced apoptosis is associated with calcium release from the ER To investigate up-stream events involved in caspase-3 activation, we studied the effect of PrPSc treatment on intracellular Ca2+ levels. N2A cells were loaded with the Ca2+-responsive fluorophore Fluo-4, to monitor changes in intracellular calcium concentrations over time. After treatment with PrPSc, a fast and sustained increase in Ca2+ levels (within minutes) was observed in a dose-dependent manner (Figure 2A). As controls, cells were treated with 100 nM recombinant PrPC or equivalent volumes of a sample prepared from non-infected brains. No effects on intracellular calcium levels were observed under these conditions (Figure 2A). These experiments were performed in the absence of extracellular calcium, indicating that Ca2+ increase stimulated by PrPSc is released from intracellular stores, such as ER or mitochondria. In order to define the source of calcium, N2A cells were pre-treated with thapsigargin (5 μM) to decrease the concentration of calcium in the ER before PrPSc addition. Decreased calcium signals were observed in cells pre-treated with thapsigargin compared with the controls, indicating that PrPSc induces an increase of intracellular calcium released mainly from the ER (Figure 2B). As positive controls, cells were treated with the ER-stress inducers brefeldin A (an inhibitor of ER–Golgi transport) and the ionophore A23187 (Figure 2C) at concentrations that induce apoptosis in N2A cells. No changes in intracellular Ca2+ levels were observed after treatment of N2A cells with staurosporine (500 nM), which is known to induce apoptosis by the calcium-independent mitochondrial pathway (Figure 2C). Figure 2.PrPSc induces a release of Ca2+ from the endoplasmic reticulum. (A) N2A cells were loaded with the Ca2+ dye Fluo-4 (10 μg/ml final concentration). Changes in fluorescence intensity were measured by using the FLIPR1 setup after addition of 33 or 66 nM PrPSc, 100 nM recombinant PrPC, or 0.5% (v/v) of a preparation from normal mouse brains (N.B.). Relative fluorescence intensity was plotted against time, and represents the average of three different experiments. (B) Cells were pre-treated with thapsigargin (5 μM) for 15 min and calcium signals were analyzed over time after addition of 80 nM PrPSc. (C) Control experiments showing that ER stress induced by brefeldin A (40 μM) or A23187 (400 nM), but not by staurosporine (25 nM) promoted calcium release. Download figure Download PowerPoint PrPSc induces ER-stress and activation of caspase-12 The main caspase associated with the ER apoptosis pathway is caspase-12, an ER-resident caspase, which upon activation by ER-stress and calcium release can promote caspase-3 mediated apoptosis (Mehmet, 2000). Treatment of N2A cells with PrPSc leads to activation of this protease, which is evidenced by the decrease of the pro-caspase-12 signal (Figure 3A, top panel). Similar results were observed when N2A cells were treated with lethal concentrations of brefeldin A, but not with staurosporine (Figure 3A, top panel). In addition, PrPSc treatment was associated with a significant increase in the expression levels of the ER chaperone Grp58. A lower but still statistically significant induction of Grp94 and Grp78 was observed (Figure 3A, see Supplementary data for statistical analysis, available at The EMBO Journal Online). No induction of Grps was observed after treatment of cells with staurosporine (Figure 3A) or with equivalent concentrations of recombinant PrPC (data not shown). Figure 3.Caspase-12 activation mediates PrPSc neurotoxicity in N2A cells. (A) Cells were treated with PrPSc (50 nM), staurosporine (25 nM) or brefeldin A (12 μM), and the levels of pro-caspase-12, Grp58, Grp78, and Grp94 were determined by western blotting. As controls the levels of actin are shown. To determine the significance of the differences in expression level, data from at least three different experiments were analyzed by densitometry (see Supplementary data). Differences on the expression of pro-caspase-12 (at 24 and 27 h), Grp94 (at 24 and 27 h), Grp78 (at 27 h) and Grp58 (at 27 h) after treatment with PrPSc were statistically significant (P < 0.005). (B) Expression levels of caspase-12 dominant-negative in three different clones termed DN12, DN18 and DN19 were determined by western blotting. These clones as well as a clone transfected with vector alone (C2) were treated with 80 nM PrPSc for 48 h. Results were analyzed statistically by non-parametric t-test comparing each result with values obtained with the control clone C2. (C) As controls, the same clones were treated with A23187 (200 nM), brefeldin A (12 μM; Bref.A) or staurosporine (25 nM; Stauro), and cell viability was determined after 48 h by MTS analysis. In panels (B) and (C), values correspond to the average and standard deviation of three determinations. Results were statistically analyzed by t-test comparing the result of each treatment with the values obtained with the same treatment of clone C2 and results are shown in the figure, using the asterisk nomenclature as described in Materials and methods. Data were also analyzed by two-way ANOVA using clones and treatment as the variables. Results were significant with P < 0.0001. Download figure Download PowerPoint To confirm the participation of caspase-12 in the PrPSc apoptotic pathway we studied the effect of over-expression of a catalytic mutant of caspase-12 [caspase-12(C298A)], that has been shown to function as a dominant-negative (Rao et al., 2002). N2A cells over-expressing the caspase-12 catalytic mutant were significantly more resistant to PrPSc toxicity (Figure 3B). As controls, the same clones were treated with different concentrations of brefeldin A, A23187 or staurosporine. Cells over-expressing the dominant-negative caspase-12 were more resistant to insult induced by the ER-stress agents brefeldin A and A23187 (Figure 3C). However, no difference was observed when an agent inducing apoptosis by the mitochondrial pathway (staurosporine) was used (Figure 3C). Recently, it has been described that under certain pathological conditions, Bcl-2 can regulate the induction of apoptosis mediated not only by mitochondrial dysfunction, but also by ER-stress (Rudner et al., 2001; Wang et al., 2001). In order to characterize further the role of ER-mediated apoptosis in PrPSc-induced cell death, N2A cells were stably transfected with a mutant form of Bcl-2 targeted to the ER (Bcl-2/ER) by replacing its transmembrane domain with the ER-insertional region of cytochrome b5 (Figure 4A). As controls we stably transfected cells with either a mutant form lacking the transmembrane domain (Bcl-2/ΔTM), which is expressed in the cytoplasm and is inactive, or with wild-type Bcl-2 (Bcl-2/WT), which is expressed in both mitochondria and ER (Figure 4A). The specific distribution of each mutant was confirmed by co-staining the cells with antibodies against Bcl-2 and the ER marker calnexin (Figure 4B). Cells transfected with Bcl-2/ER completely overlapped in double stained preparations with a perinuclear distribution typical of the ER–Golgi network. As expected, Bcl-2/ΔTM clones showed staining throughout the cell (including the nucleus), whereas Bcl-2/WT exhibited a cytoplasmatic distribution, which partially colocalized with calnexin (Figure 4B). Figure 4.Bcl-2 targeted to the ER decreases the sensitivity of N2A cells to PrPSc toxicity and caspase-12 activation. (A) Cells were stably transfected with Bcl-2/ER, Bcl-2-ΔTM and Bcl-2WT constructs or with empty vector, and Bcl-2 protein levels were analyzed by western blotting in different cellular clones. (B) In parallel, Bcl-2 distribution was detected by immunofluorescence in selected clones. Bcl-2 staining is shown in green; calnexin staining is shown in red and nuclear labeling with Hoechst33342 is shown in blue. (C) As controls, Bcl-2 transfected clones and control cells were treated with 150 nM staurosporine for 24 h. (D) The same N2A cell clones were treated with 50 nM PrPSc for 48 h, and cell viability was assessed using MTS analysis. In the last two panels, statistical analysis was performed comparing the cell viability values for each transfected clone with the results obtained with the control clone C1. (E) Cells transfected with vector alone (C1 clone) or with Bcl-2/ER (clones 5 and 7) were treated with 50 nM PrPSc. Caspase-12 activation was analyzed by western blot. The significance of the differences in pro-caspase-12 expression was estimated by densitometric analysis of the blots. Download figure Download PowerPoint Treatment of the different cell clones with staurosporine showed that only the wild-type Bcl-2 expressing cells were significantly protected from the toxic effect of this agent (Figure 4C). The two clones expressing Bcl-2/ER (clones C5 and C7) showed significant protection against PrPSc when compared with cells transfected with vector alone (Figure 4D). Moreover, cells expressing Bcl-2/WT, which is targeted to both mitochondria and ER, did not result in significantly further inhibition of neurotoxicity compared with Bcl-2/ER, suggesting that mitochondrial Bcl-2 does not contribute to inhibit apoptosis induced by PrPSc (Figure 4D). Interestingly, the inhibition of cellular death in the clones expressing Bcl-2/ER was associated with a decrease in activation of caspase-12 (Figure 4E), further supporting the link between ER-stress and caspase-12 activation in the PrPSc apoptotic pathway. PrPSc replication sensitizes N2A cells to ER-stress-induced apoptosis It has been described that a hypothalamic neuronal cell line persistently infected with scrapie prions has the ability to convert endogenous PrPC into PrPSc, and exhibits typical morphological and biochemical features of apoptosis (Schatzl et al., 1997). However, in most neuronal lines chronically infected with prions, including N2A cells, there are no signs of cellular death (Rubenstein et al., 1984; Butler et al., 1988). In order to analyze the effect of PrPSc replication on cellular dysfunction, we studied the vulnerability to toxic stress of N2A cells chronically infected with RML prions (ScN2A). These cells propagate protease-resistant prion protein (Figure 5A) and carry infectivity (Butler et al., 1988). Even though there are no evident effects on cellular viability following prion infection, treatment with different ER-stress inducers, including thapsigargin, tunicamycin, brefeldin A and the ionophore A23187, revealed that ScN2A cells are more sensitive to ER-stress mediated cell death than non-infected N2A cells (Figure 5B). In control experiments, no differential effect was observed when ScN2A and N2A cells were treated with inducers of mitochondrial stress, such as staurosporine (Figure 5C) or serum deprivation (data not shown). These data suggest that PrPSc replication induces ER-stress, and although this does not lead directly to cell death, it nevertheless sensitizes the cells to subsequent apoptotic stimuli, which target the ER-associated pathway. Figure 5.PrPSc-replication sensitizes N2A cells to ER-stress mediated apoptosis. (A) Scrapie-infected N2A cells replicate the protease-resistant PrPSc form, whereas the non-infected cells contain only PK-sensitive PrPC, as analyzed by western blot. (B) ScN2A and N2A cells were treated with different concentrations of tunicamycin, A23187, thapsigargin (Thaps) or brefeldin A for 48 h, and cell viability was quantified using MTS. Filled bars represent infected cells and empty bars indicates non-infected cells. Data were analyzed by t-test comparing the values of infected and non-infected cells for each treatment (***P < 0.005) and by two-way ANOVA using treatment and cells (infected and non-infected) as the variables (P < 0.0001). (C) As controls, cells were treated with different concentrations of staurosporine for 48 h, and cellular viability was quantified by MTS analysis. (D) N2A and ScN2A cells were treated with PrPSc, and cell viability was analyzed after 48 h using MTS. Data in panels (B, C and D) represent two independent experiments performed in triplicate. Parametric t-test was used to analyze statistical significance comparing for each condition the values of non- infected versus infected cells. Download figure Download PowerPoint A possible explanation for the lack of toxicity of endogenous PrPSc produced in N2A cells is that since these cells divide rapidly, they do not accumulate enough PrPSc to lead to cell death. To test this hypothesis, we analyzed the extent of cell death induced by purified PrPSc in infected and non-infected N2A. Addition of PrPSc to the culture medium produced a higher toxicity in ScN2A cells than in non-infected cells (Figure 5D). Interestingly, low concentrations of PrPSc (25 nM) that in non-infected cells do not produce toxicity, in ScN2A lead to significant cell death (Figure 5D). No effects on cellular viability were observed when infected and non-infected cells were treated with recombinant PrPC or an equivalent sample prepared from non-infected brains (Figure 5D). These data reinforce the hypothesis that PrPSc damages the cells by the ER-stress pathway. Neuronal loss in murine scrapie is associated with the activation of caspase-12 and the up-regulation of Grp58 To validate the participation of caspase-12 during the development of prion disease in vivo, C57BL/6J mice were infected with 139A-scrapie and caspase-12 activation was analyzed by western blotting in different brain areas of symptomatic animals. Figure 6A shows that the active fragments of caspase-12 (p42/35) can be detected mainly in the hippocampus, thalamus and brain stem, whereas no clear signal was detected in cortex and cerebellum. This pattern was representative of the results obtained in several animals in late stages of the disease. No evidence of active caspase-12 fragments was ever detected in normal animals of the same age. The appearance of the active fragments was not paralleled by a noticeable decrease in pro-caspase-12 signal, most likely because of the high complexity of the brain extracts in terms of cellular type diversity and the selective neuronal cell death observed in scrapie. In control experiments, we analyzed the activation of caspase-8, observing no significant changes in the pro-caspase-8 form, and no increase in the levels of the active fragments (Figure 6A; p43/41). After histological analysis of the same brain areas it was possible to observe a correlation between the degree of caspase-12 activation and the extent of neuronal loss (Figure 6B). The highest levels of caspase-12 active fragments and neuronal death were found in the hippocampus, pyramidal cell layer and the thalamus, whereas in the cortex despite significant neuronal distortion little cell loss was observed, correlating with the absence of caspase-12 activation. Figure 6.Neuronal loss in murine scrapie is associated with activation of caspase-12 and up-regulation of Grp58. (A) Activation of caspase-12 and caspase-8 was analyzed by western blotting in different brain areas, including anterior cortex (CxA), posterior cortex (Cxp), cerebellum (Cereb), brain stem (BS), thalamus (Thal) and hippocampus (Hip). (B) Neuronal loss in hippocampus, thalamus and cortex was measured by immunohistochemical staining with Neu-N, a neuronal-specific marker. (C) Expression levels of Grp58, Grp94 and Hsp70 were analyzed in the same brain areas described in (A). (D) PrPSc levels were quantified after PK treatment of different brains areas from scrapie-infected and control animals. Results are representative of the data obtained with three different controls and scrapie-infected animals. The first lane shows a normal brain homogenate (NBH) before PK treatment. Download figure Download PowerPoint We then analyzed marker